Skip to main content

Research Repository

Advanced Search

Do patient characteristics matter when calculating sample size for eczema clinical trials?

Howells, L.; Gran, S.; Chalmers, J. R.; Stuart, B.; Santer, M.; Bradshaw, L.; Gaunt, D. M.; Ridd, M. J.; Gerbens, L. A. A.; Spuls, P. I.; Huang, C.; Francis, N. A.; Thomas, K. S.

Do patient characteristics matter when calculating sample size for eczema clinical trials? Thumbnail


Authors

LAURA HOWELLS LAURA.HOWELLS1@NOTTINGHAM.AC.UK
Senior Research Fellow

SONIA GRAN SONIA.GRAN@NOTTINGHAM.AC.UK
Associate Professor

J. R. Chalmers

B. Stuart

M. Santer

D. M. Gaunt

M. J. Ridd

L. A. A. Gerbens

P. I. Spuls

C. Huang

N. A. Francis



Abstract

Background: The Patient-Oriented Eczema Measure (POEM) is the core outcome instrument recommended for measuring patient-reported atopic eczema symptoms in clinical trials. To ensure that the statistical significance of clinical trial results is meaningful, trials are often designed by specifying the target difference in the primary outcome as part of the sample size calculation. One method used to specify the target difference is a score that corresponds to a standardised effect size.
Objectives: to assess how the standardised effect size of POEM scores vary across age, gender, ethnicity and disease severity.
Methods: This study combined data from five UK-based randomised clinical trials of eczema treatments in order to assess differences in self-reported eczema symptoms (POEM) corresponding to a standardised effect size (0.5 SD of baseline POEM scores) across age, gender, ethnicity and disease severity.
Results: POEM scores corresponding to 0.5 SD(baseline) were remarkably consistent across participants of varying ages, gender, ethnicity and disease severity from datasets of five UK trials in children (range 2.99 to 3.45).
Conclusions: This study provides information that can support those designing clinical trials to determine their sample size and can aid individuals interpreting trial results. Further exploration of differences in populations beyond the UK is needed.

Journal Article Type Article
Acceptance Date Apr 22, 2021
Online Publication Date May 19, 2021
Publication Date 2021-09
Deposit Date Apr 30, 2021
Publicly Available Date May 19, 2021
Journal Skin Health and Disease
Electronic ISSN 2690-442X
Peer Reviewed Peer Reviewed
Volume 1
Issue 3
Article Number e42
DOI https://doi.org/10.1002/ski2.42
Public URL https://nottingham-repository.worktribe.com/output/5504211
Publisher URL https://onlinelibrary.wiley.com/doi/10.1002/ski2.42

Files





You might also like



Downloadable Citations